UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000060270
Receipt number	R000068941
Scientific Title	An Open-Label, Single-Arm Phase II Study of Enfortumab Vedotin Plus Pembrolizumab in Patients with Unresectable Urothelial Carcinoma
Date of disclosure of the study information	2026/01/06
Last modified on	2026/01/06 15:00:17

---